Millennium Management
SNTI icon

Millennium Management’s Senti Biosciences Holdings SNTI Stock Holding History

Millennium Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,334
Closed -$5.03K – 6486
2024
Q1 		$5.03K Sell
1,334
-108
-7% -$483 ﹤0.01% 6006
2023
Q4 		$9.51K Buy
+1,442
New +$5.62K ﹤0.01% 5747
2023
Q1 		– Sell
-2,269
Closed -$32K – 6826
2022
Q4 		$32K Sell
2,269
-2,100
-48% -$51.2K ﹤0.01% 5914
2022
Q3 		$95K Buy
4,369
+747
+21% +$14.7K ﹤0.01% 5988
2022
Q2 		$71K Sell
3,622
-80,957
-96% -$6.5M ﹤0.01% 6058
2022
Q1 		$8.35M Buy
84,579
+42,763
+102% +$4.22M ﹤0.01% 2352
2021
Q4 		$4.12M Sell
41,816
-2,269
-5% -$226K ﹤0.01% 3102
2021
Q3 		$4.38M Buy
44,085
+495
+1% +$48.8K ﹤0.01% 3015
2021
Q2 		$4.33M Buy
+43,590
New +$4.35M ﹤0.01% 2944

Other funds holding SNTI

8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management's SNTI Position: Q2 2024 in Review

Millennium Management sold out of Senti Biosciences Holdings (SNTI) in Q2 2024, closing a stake of 1,334 shares — an estimated $5.03K sold.

Millennium Management first reported a position in SNTI in Q2 2021 and held it in 9 quarters. The position peaked at $8.35M in Q1 2022. 20 funds tracked by Wall St. Rank hold SNTI as of Q2 2024.

  • Millennium Management reported no remaining Senti Biosciences Holdings position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 1,334 Senti Biosciences Holdings shares in Q2 2024, an estimated $5.03K.
  • Millennium Management first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 9 quarters.
  • Millennium Management's Senti Biosciences Holdings position peaked at $8.35M in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.